ExploreWatchlistsPricing
  1. JP-listed companies
  2. TORII PHARMACEUTICAL CO., LTD.
  3. Financials
  4. Cash from operations

TORII PHARMACEUTICAL CO., LTD. (E00934)

Market cap
P/E ratio
Torii Pharmaceutical manufactures and sells prescription medicines for kidney disease, skin conditions, allergies, and other medical needs in Japan.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndCash from operations (Million JPY)YoY (%)
Dec 31, 20243,639-216.52%
Dec 31, 2023-3,123-229.05%
Dec 31, 20222,420-1651.28%
Dec 31, 2021-156-95.47%
Dec 31, 2020-3,443-108.10%
Dec 31, 201942,499+414.58%
Dec 31, 20188,259+30.08%
Dec 31, 20176,349+86.63%
Dec 31, 20163,402-31.13%
Dec 31, 20154,940-911.17%
Dec 31, 2014-609

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat